Guideline Adherence Impacts Mortality in Schizophrenia

Share on FacebookTweet about this on TwitterShare on LinkedIn

Adherence to the 2009 Schizophrenia Patient Outcomes Research Team (PORT) pharmacologic guidelines appears to help reduce mortality among patients with schizophrenia, according to a study from Johns Hopkins University. The authors recommend that clinicians consider adopting outcomes-monitoring systems and innovative service delivery programs to improve adherence to the PORT guidelines.

Abstract: Schizophrenia Bulletin, October 30, 2012 (online).

Submit a Comment

Your email address will not be published. Required fields are marked *

3 + 20 =